XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Debt (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 14, 2023
Mar. 31, 2022
Dec. 27, 2019
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Apr. 23, 2023
May 14, 2020
Apr. 24, 2019
Debt [Line Items]                      
Debenture                     $ 3,000,000
Amortization discount       $ 0 $ 24,613 $ 0 $ 48,759        
Interest expense   $ 17,912   $ 0   $ 0 61,614        
Vested warrants           5 years          
Common stock, shares issued (in Shares) [1]       1,017,198   1,017,198   484,187      
Conversion rate, percentage           80.00%          
Converted shares (in Shares)   92,362       6,661          
Gross proceeds           $ 1,914,513        
Initial public offering discount, percentages           15.00%          
Common stock outstanding, percentages           19.90%          
Milestone payment           $ 10,000,000          
Regulatory advice value           $ 30,000          
Cumulative dividend       6.00%   6.00%          
Common stock ownership percentage       19.90%   19.90%          
Equal royalty pay to lender, percentage           $ 3.5          
Extinguishment loss             839,887        
Debt issuance costs                     2,100,000
Current maturity       $ 8,772   8,772   $ 8,772      
Total Long-Term Liabilities       $ 148,670   $ 148,670   150,251      
Knight Therapeutics, Inc. [Member]                      
Debt [Line Items]                      
Principal amount     $ 6,309,823                
Accrued interest     4,160,918                
Debenture     $ 3,483,851                
Annual interest rate                 15.00%    
Debenture interest rate                 9.00%    
Note [Member]                      
Debt [Line Items]                      
Interest expense         31,352            
2022 Bridge Notes [Member]                      
Debt [Line Items]                      
Annual interest rate       15.00%   15.00%          
Debenture interest rate       10.00%   10.00%          
Face amount, percentage           100.00%          
2022 and 2023 Bridge Notes [Member]                      
Debt [Line Items]                      
Settlement of outstanding debt obligations       $ 1,749,488              
Two Thousand Twenty Three Bridge Notes [Member]                      
Debt [Line Items]                      
Annual interest rate       15.00%   15.00%          
Debenture interest rate       10.00%   10.00%          
Amortization discount       $ 0 $ 307,910 $ 0 $ 645,336        
Knight’s Cumulative Debt [Member]                      
Debt [Line Items]                      
Principal amount   $ 10,770,037                  
Accumulated interest   $ 8,096,486                  
Debenture [Member]                      
Debt [Line Items]                      
Amortized interest expense                     $ 13,696
Small Business Administration [Member]                      
Debt [Line Items]                      
Principal amount                   $ 150,000  
Annual interest rate                   3.75%  
Principal payments       157,442   157,442   159,023      
Balloon Payment [Member]                      
Debt [Line Items]                      
Balloon payment       28,154   28,154          
Preferred Stock [Member]                      
Debt [Line Items]                      
Accumulated interest       $ 100   $ 100          
Knight Debt [Member]                      
Debt [Line Items]                      
Ownership percentage   19.90%                  
Series A Preferred Stock [Member]                      
Debt [Line Items]                      
Common stock, shares issued (in Shares)       1,017,198   1,017,198          
Converted shares (in Shares)   80,965                  
IPO [Member]                      
Debt [Line Items]                      
Accrued interest           $ 31,968          
Vested warrants           1 year          
Fully vested warrants exercise price percentage           110.00%          
Common stock, shares issued (in Shares)       25,335   25,335          
Conversion rate, percentage           20.00%          
Gross proceeds $ 6,454,325             $ 7,000,000      
IPO [Member] | Chief Executive Officer [Member]                      
Debt [Line Items]                      
Conversion rate, percentage           90.00%          
[1] Periods presented have been adjusted to reflect the 1:12 reverse stock split on August 12, 2024. See Note 12 - Subsequent Events for more information.